|
CABP1 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.45970013853969E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19919999486129E-08 |
| Normal-vs-Stage2 |
1.91942999999695E-05 |
| Normal-vs-Stage3 |
3.095100E-03 |
| Normal-vs-Stage4 |
6.750000E-02 |
| Stage1-vs-Stage2 |
4.356300E-02 |
| Stage1-vs-Stage3 |
4.199800E-02 |
| Stage1-vs-Stage4 |
2.563600E-01 |
| Stage2-vs-Stage3 |
3.543900E-03 |
| Stage2-vs-Stage4 |
1.544360E-02 |
| Stage3-vs-Stage4 |
9.189400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37319999984997E-07 |
| Normal-vs-AfricanAmerican |
3.241200E-01 |
| Normal-vs-Asian |
3.93610000000155E-05 |
| Caucasian-vs-AfricanAmerican |
5.331800E-01 |
| Caucasian-vs-Asian |
3.626400E-02 |
| AfricanAmerican-vs-Asian |
8.614300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.94179999968291E-07 |
| Normal-vs-Female |
2.41570000003577E-07 |
| Male-vs-Female |
5.922700E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.7975599999942E-05 |
| Normal-vs-Age(41-60Yrs) |
3.60609999972006E-07 |
| Normal-vs-Age(61-80Yrs) |
5.64389999999637E-05 |
| Normal-vs-Age(81-100Yrs) |
3.518800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.561600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.441400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.894400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.199630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.161400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.642000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.128200E-02 |
| Classical-VS-Follicular |
5.357500E-04 |
| Classical-VS-Other |
2.091200E-01 |
| Classical-VS-Normal |
5.59900000030034E-07 |
| Tall-VS-Follicular |
3.78979999999807E-05 |
| Tall-VS-Other |
1.885750E-02 |
| Tall-VS-Normal |
3.576200E-01 |
| Follicular-VS-Other |
7.726600E-01 |
| Follicular-VS-Normal |
2.87360000239545E-08 |
| Other-VS-Normal |
3.709600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.88649992796763E-10 |
| Normal-vs-N1 |
9.239300E-03 |
| N0-vs-N1 |
1.053000E-01 |
|
|
